These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21450189)

  • 1. Patterns of dementia treatment use in assisted living facilities: a cross-sectional study of 1975 demented residents.
    Barro-Belaygues N; Abellan van Kan G; Rolland Y; Nourhashemi F; Soto-Martin M; Gillette-Guyonnet S; Vellas B
    J Am Med Dir Assoc; 2011 Nov; 12(9):648-54. PubMed ID: 21450189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study.
    Foebel AD; Liperoti R; Onder G; Finne-Soveri H; Henrard JC; Lukas A; Denkinger MD; Gambassi G; Bernabei R;
    J Am Med Dir Assoc; 2014 Dec; 15(12):911-7. PubMed ID: 25262195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland.
    Rosenblatt A; Samus QM; Steele CD; Baker AS; Harper MG; Brandt J; Rabins PV; Lyketsos CG
    J Am Geriatr Soc; 2004 Oct; 52(10):1618-25. PubMed ID: 15450036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive study of nursing home residents from the REHPA network.
    Rolland Y; Abellan van Kan G; Hermabessiere S; Gerard S; Guyonnet Gillette S; Vellas B
    J Nutr Health Aging; 2009 Oct; 13(8):679-83. PubMed ID: 19657550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emperor has no clothes: dementia treatment on the eve of the aging era.
    Royall DR
    J Am Geriatr Soc; 2005 Jan; 53(1):163-4. PubMed ID: 15667396
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study.
    Leroi I; Samus QM; Rosenblatt A; Onyike CU; Brandt J; Baker AS; Rabins P; Lyketsos C
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):224-32. PubMed ID: 17044133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
    Rosenblatt A; Samus QM; Onyike CU; Baker AS; McNabney M; Mayer LS; Brandt J; Lyketsos CG
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):178-84. PubMed ID: 17676652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underrecognition of cognitive impairment in assisted living facilities.
    Magsi H; Malloy T
    J Am Geriatr Soc; 2005 Feb; 53(2):295-8. PubMed ID: 15673355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey.
    Seitz DP; Gruneir A; Conn DK; Rochon PA
    J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.
    Stock KJ; Amuah JE; Lapane KL; Hogan DB; Maxwell CJ
    Drugs Aging; 2017 Jan; 34(1):39-53. PubMed ID: 27830567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic drug consumption at admission and discharge of nursing home residents.
    Rolland Y; Andrieu S; Crochard A; Goni S; Hein C; Vellas B
    J Am Med Dir Assoc; 2012 May; 13(4):407.e7-12. PubMed ID: 22264687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dementia and treatment of dementia on time to discharge from assisted living facilities: the Maryland assisted living study.
    Lyketsos CG; Samus QM; Baker A; McNabney M; Onyike CU; Mayer LS; Brandt J; Rabins P; Rosenblatt A
    J Am Geriatr Soc; 2007 Jul; 55(7):1031-7. PubMed ID: 17608875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indicators of benzodiazepine use in nursing home residents in France: a cross-sectional study.
    de Souto Barreto P; Lapeyre-Mestre M; Mathieu C; Piau C; Bouget C; Cayla F; Vellas B; Rolland Y
    J Am Med Dir Assoc; 2013 Jan; 14(1):29-33. PubMed ID: 23098415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'].
    van Gool WA; Stam CJ; Steenhoek A; Hagemeijer A
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):839-43. PubMed ID: 16676513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.